Emily DuComb, DO
Dr. Emily DuComb is a pulmonologist and critical care medicine specialist at the University of Michigan’s Rogel Cancer Center and Michigan Health. Her clinical specialty is caring for patients with complex airway and pleural disorders who require the help of interventional pulmonology techniques, including minimally invasive bronchoscopic biopsies and robotic bronchoscopy, as well as treatment for pleural effusions.[1]
Dr. DuComb cares for patients with lung nodules and thoracic malignancies as well as benign conditions including asthma, COPD, and airway stenosis. She works as part of the multidisciplinary Interventional Pulmonary Program to provide leading-edge treatment options for her patients.
Education and Career
Dr. DuComb is board-certified in Critical Care Medicine, Internal Medicine, Interventional Pulmonology, and Pulmonary Disease. Her educational journey began at the Michigan State University College of Osteopathic Medicine where she earned her Doctor of Osteopathic Medicine degree. She then pursued her residency in Internal Medicine at Beaumont Health (Royal Oak), where she continued as Chief Resident in Internal Medicine. She then completed a fellowship in Pulmonary Disease and Critical Care Medicine at the University of Vermont Medical Center and another in Interventional Pulmonology at Harvard Medical School – Beth Israel Deaconess Medical Center and Massachusetts General Hospital.[1]
In addition to her patient responsibilities and role as Clinical Assistant Professor at the University of Michigan Health, Dr. DuComb is a faculty member of the American Association for Bronchology and Interventional Pulmonology.
Research
Dr. DuComb is actively involved in clinical trials researching advanced diagnostic and therapeutic interventions for patients with advanced thoracic malignancies and early and late-stage lung cancers. Some of her publications include:[1]
Endobronchial ultrasound-guided transbronchial needle injection of cisplatin results in dynamic changes in the tumor immune microenvironment.Emily A DuComb, Cheryl C Collins, Dolores Cupak, Sarah Wagner, Farrah B Khan, Ralph C Budd, C Matthew Kinsey> Respiratory Medicine and Research. 2023 Jan 10
Visualizing intratumoral injections in lung tumors by endobronchial ultrasound. Vitor Mori, Emily A DuComb, Sarah Wagner, Farrah Khan, Jason H T Bates, C Matthew Kinsey> Journal of Cancer. 2023 Jan 1
Evidence for Expanding Invasive Mediastinal Staging for Peripheral T1 Lung Tumors. Emily A. DuComb, Benjamin A. Tonelli, Ya Tuo, Bernard F. Cole, Vitor Mori, Jason H. T. Bates, George R. Washko, Raúl San José Estépar, C. Matthew Kinsey> Chest. 2020 Jun 26
Terri Heimann Oppenheimer
WriterTerri Oppenheimer has been writing about mesothelioma and asbestos topics for over ten years. She has a degree in English from the College of William and Mary. Terri’s experience as the head writer of our Mesothelioma.net news blog gives her a wealth of knowledge which she brings to all Mesothelioma.net articles she authors.
Dave Foster
Page EditorDave has been a mesothelioma Patient Advocate for over 10 years. He consistently attends all major national and international mesothelioma meetings. In doing so, he is able to stay on top of the latest treatments, clinical trials, and research results. He also personally meets with mesothelioma patients and their families and connects them with the best medical specialists and legal representatives available.
References
- Rogel Cancer Center. (N.D.). Emily Anne DuComb, DO.
Retrieved from: https://www.rogelcancercenter.org/physicians/emily-anne-ducomb-do